Response to "in vivo secretion of anti-CD3 × anti-tumor bispecific antibodies by gene-modified cells: over a decade of T-cell engagement"

Mol Ther. 2015 Apr;23(4):613. doi: 10.1038/mt.2015.37.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Animals
  • Antigens, Neoplasm / immunology*
  • Brain Neoplasms / therapy*
  • Glioma / therapy*
  • Humans
  • Immunotherapy, Adoptive / methods*
  • Lung Neoplasms / therapy*
  • Male
  • T-Lymphocytes / immunology*

Substances

  • Antigens, Neoplasm